- aplastic anemia
- myelodysplastic syndromes (MDS)
- myeloproliferative neoplasms (MPN)
Tiffany N. Tanaka, MD, is a board-certified hematologist specializing in the diagnosis and treatment of blood cancers and blood disorders, with an emphasis on myeloid malignancies.
Dr. Tanaka is a translational researcher who focuses on the development of early phase trials that offer new cancer treatments for patients. Her research work includes the study of epigenetic and genetic biomarkers in myelodysplastic syndromes (bone marrow disorders in which the bone marrow does not produce enough healthy blood cells), with the aim of translating these into clinical therapies to improve patient care. Dr. Tanaka is a member of the American Society of Hematology, where she has presented her research work.
Dr. Tanaka completed a fellowship in hematology and oncology at UC San Diego School of Medicine, where she also completed a residency in internal medicine. She earned her medical degree from John A. Burns School of Medicine at the University of Hawai’i. She is board certified in internal medicine and hematology.
- accepting new patients